These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10021903)

  • 1. [Glucocorticoids and multiple myeloma. Mechanism of action, resistance and clinical use].
    Paule B; Clerc D; Brion N
    Ann Med Interne (Paris); 1998 Dec; 149(8):502-7. PubMed ID: 10021903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of glucocorticoids in the treatment of multiple myeloma].
    Juge-Morineau N; Harousseau JL; Bataille R
    Ann Med Interne (Paris); 1996; 147(8):576-9. PubMed ID: 9137685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
    Neri P; Yasui H; Hideshima T; Tassone P; Raje N; Catley LP; Ishitsuka K; Blotta S; Kiziltepe T; Ocio EM; Fulciniti M; Kanekal S; Elliott GT; Munshi NC; Anderson KC
    Br J Haematol; 2006 Jul; 134(1):37-44. PubMed ID: 16803565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone.
    Tassone P; Forciniti S; Galea E; Savino R; Turco MC; Iacopino P; Tagliaferri P; Morrone G; Ciliberto G; Venuta S
    Cell Death Differ; 2000 Mar; 7(3):327-8. PubMed ID: 10866493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induction of apoptosis in lymphocytes by glucocorticoids: between physiology and pharmacology].
    Pallardy M; Biola A
    C R Seances Soc Biol Fil; 1998; 192(6):1051-63. PubMed ID: 10101602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
    Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in multiple myeloma: approaches to circumvention.
    Dalton WS; Jove R
    Semin Oncol; 1999 Oct; 26(5 Suppl 13):23-7. PubMed ID: 10528891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.
    Tassone P; Galea E; Forciniti S; Tagliaferri P; Venuta S
    Int J Oncol; 2002 Oct; 21(4):867-73. PubMed ID: 12239628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis.
    Yang HH; Ma MH; Vescio RA; Berenson JR
    J Clin Oncol; 2003 Nov; 21(22):4239-47. PubMed ID: 14615454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
    Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids in multiple myeloma: past, present, and future.
    Burwick N; Sharma S
    Ann Hematol; 2019 Jan; 98(1):19-28. PubMed ID: 30073393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells.
    de Lange P; Segeren CM; Koper JW; Wiemer E; Sonneveld P; Brinkmann AO; White A; Brogan IJ; de Jong FH; Lamberts SW
    Cancer Res; 2001 May; 61(10):3937-41. PubMed ID: 11358809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells.
    Efferth T; Fabry U; Osieka R
    Anticancer Res; 2002; 22(1A):231-4. PubMed ID: 12017294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic or antiestrogenic therapies for multiple myeloma?
    Sola B; Renoir JM
    Mol Cancer; 2007 Sep; 6():59. PubMed ID: 17888187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimyeloma effects of a sesquiterpene lactone parthenolide.
    Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
    Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in multiple myeloma.
    Sonneveld P
    Pathol Biol (Paris); 1999 Feb; 47(2):182-7. PubMed ID: 10192886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.